RxNorm Semantic Concepts Index - 477
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "477".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 477024 | diphenhydramine citrate 19 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 477024 | diphenhydramine citrate 19 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 477031 | salicylic acid 6 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 477031 | salicylic acid 6 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 477031 | salicylic acid 6 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 477045 | chlorpheniramine maleate 2 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 477045 | chlorpheniramine maleate 2 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 477045 | chlorpheniramine maleate 2 MG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 477050 | cinnamon bark 500 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 477050 | cinnamon bark 500 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 477051 | cinnamon bark 500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 477053 | cinnamon bark | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 477054 | cinnamon bark Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 477064 | APAP 325 MG / phenyltoloxamine citrate 25 MG / salicylamide 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 477064 | APAP 325 MG / phenyltoloxamine citrate 25 MG / salicylamide 200 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 477092 | brompheniramine / dextromethorphan / phenylephrine Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 477094 | chlorpheniramine / dextromethorphan / phenylephrine Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 47711 | Carbon monoxide dehydrogenase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 47711 | Carbon monoxide dehydrogenase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 477126 | urea 35 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 477126 | urea 35 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 477126 | urea 35 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 477127 | urea 350 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 477130 | telmisartan 80 MG / hydroCHLOROthiazide 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 477130 | telmisartan 80 MG / hydroCHLOROthiazide 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 477130 | telmisartan 80 MG / hydroCHLOROthiazide 25 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 477130 | telmisartan 80 MG / hydroCHLOROthiazide 25 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 477130 | telmisartan 80 MG / hydroCHLOROthiazide 25 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 477130 | telmisartan 80 MG / hydroCHLOROthiazide 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 477139 | voriconazole 40 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 477141 | voriconazole Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 477144 | acetylcarnitine 500 MG / alpha lipoic acid 200 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 477144 | acetylcarnitine 500 MG / alpha lipoic acid 200 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 477174 | zinc oxide 16 % Topical Paste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 477174 | zinc oxide 16 % Topical Paste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 477174 | zinc oxide 16 % Topical Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 477174 | zinc oxide 16 % Topical Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 477175 | zinc oxide 0.16 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 477180 | zinc oxide 30.6 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 477180 | zinc oxide 30.6 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 477180 | zinc oxide 30.6 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 477180 | zinc oxide 30.6 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 477181 | zinc oxide 306 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 477189 | saw palmetto berry extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 477189 | saw palmetto berry extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 47720 | Carboxylate reductase | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 47720 | Carboxylate reductase | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 477201 | Zinc amino acid chelate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 477201 | Zinc amino acid chelate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 477204 | testosterone 10 MG/ML Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 477215 | sulfonated phenol 50 % / sulfuric acid 30 % Mucous Membrane Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 477215 | sulfonated phenol 50 % / sulfuric acid 30 % Mucous Membrane Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 477215 | sulfonated phenol 50 % / sulfuric acid 30 % Mucous Membrane Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 477216 | sulfuric acid 300 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 477218 | sulfonated phenol 500 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 477221 | carbinoxamine tannate 0.72 MG/ML / pseudoephedrine tannate 9.1 MG/ML Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 477222 | pseudoephedrine tannate 9.1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 477224 | carbinoxamine / pseudoephedrine Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 477225 | urea 50 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 477225 | urea 50 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 477225 | urea 50 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 477234 | tinidazole 250 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 477234 | tinidazole 250 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 477234 | tinidazole 250 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 477234 | tinidazole 250 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 477235 | tinidazole 250 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 47724 | Cathepsin A | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 47724 | Cathepsin A | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 47724 | Cathepsin A | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 47724 | Cathepsin A | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 477245 | diphenhydrAMINE citrate 19 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 477245 | diphenhydrAMINE citrate 19 MG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 477245 | diphenhydrAMINE citrate 19 MG Disintegrating Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 477246 | diphenhydrAMINE Disintegrating Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 477246 | diphenhydrAMINE Disintegrating Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 477260 | lansoprazole 6 MG/ML Injectable Solution | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 477260 | lansoprazole 6 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 477260 | lansoprazole 6 MG/ML Injectable Solution | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 477261 | lansoprazole 6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 477263 | lansoprazole Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 477282 | acetaminophen 160 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 477282 | acetaminophen 160 MG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 477282 | acetaminophen 160 MG Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 477320 | Erlotinib hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 477320 | Erlotinib hydrochloride | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 477320 | Erlotinib hydrochloride | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 477321 | erlotinib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 477336 | guaiFENesin 1200 MG / dextromethorphan HBr 20 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 477336 | guaiFENesin 1200 MG / dextromethorphan HBr 20 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 477336 | guaiFENesin 1200 MG / dextromethorphan HBr 20 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 477336 | guaiFENesin 1200 MG / dextromethorphan HBr 20 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 477336 | guaiFENesin 1200 MG / dextromethorphan HBr 20 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 47734 | Carfentanil citrate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 47734 | Carfentanil citrate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 477343 | lanthanum carbonate 250 MG Chewable Tablet | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 477343 | lanthanum carbonate 250 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 477343 | lanthanum carbonate 250 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 477343 | lanthanum carbonate 250 MG Chewable Tablet | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 477344 | lanthanum carbonate 250 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 477346 | lanthanum carbonate Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 477347 | lanthanum carbonate 500 MG Chewable Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 477347 | lanthanum carbonate 500 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 477347 | lanthanum carbonate 500 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 477347 | lanthanum carbonate 500 MG Chewable Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 477348 | lanthanum carbonate 500 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 477359 | phenylephrine Disintegrating Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 477362 | solfenacin succinate 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 477363 | solfenacin succinate 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 477364 | solfenacin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 477365 | solfenacin succinate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 477366 | solfenacin Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 477367 | solifenacin succinate 5 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 477367 | solifenacin succinate 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 477367 | solifenacin succinate 5 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 477367 | solifenacin succinate 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 477368 | solifenacin succinate 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 477371 | solifenacin Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 477372 | solifenacin succinate 10 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 477372 | solifenacin succinate 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 477372 | solifenacin succinate 10 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 477372 | solifenacin succinate 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 477373 | solifenacin succinate 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 477379 | Echinacea root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 477381 | coenzyme Q10 30 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 477381 | coenzyme Q10 30 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 477381 | coenzyme Q10 30 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 477391 | levoFLOXacin 25 MG in 1 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 477391 | levoFLOXacin 25 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 477391 | levoFLOXacin 25 MG in 1 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 477391 | levoFLOXacin 25 MG in 1 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 477391 | levoFLOXacin 25 MG in 1 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 477391 | levoFLOXacin 25 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 477391 | levoFLOXacin 25 MG in 1 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 477391 | levoFLOXacin 25 MG in 1 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 477391 | levoFLOXacin 25 MG in 1 mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 477391 | levoFLOXacin 25 MG in 1 mL Oral Solution | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 477391 | levoFLOXacin 25 MG in 1 mL Oral Solution | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 477392 | levofloxacin Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 477392 | levofloxacin Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 477397 | Morphine sulfate liposome | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| Concept ID (RxCUI): 477397 | Morphine sulfate liposome | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 477397 | Morphine sulfate liposome | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 477397 | Morphine sulfate liposome | British synonym (SYGB) | British synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 4774 | Genome | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 4774 | Genome | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 477429 | selenium sulfide 22.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 477433 | ubidecarenone 60 MG / vitamin E acetate 150 UNT Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 477433 | ubidecarenone 60 MG / vitamin E acetate 150 UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 477433 | ubidecarenone 60 MG / vitamin E acetate 150 UNT Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 477437 | ubidecarenone 15 MG / vitamin E acetate 3 UNT Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 477437 | ubidecarenone 15 MG / vitamin E acetate 3 UNT Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 477437 | ubidecarenone 15 MG / vitamin E acetate 3 UNT Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 477450 | chlordiazepoxide / methscopolamine Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 477450 | chlordiazepoxide / methscopolamine Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| Concept ID (RxCUI): 477451 | clindamycin phosphate 1 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 477451 | clindamycin phosphate 1 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 477451 | clindamycin phosphate 1 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 477451 | clindamycin phosphate 1 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 477451 | clindamycin phosphate 1 % Topical Foam | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 477451 | clindamycin phosphate 1 % Topical Foam | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 477452 | clindamycin Topical Foam | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 477454 | collagen, hydrolyzed | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 477459 | cyanocobalamin 2 MG / folic acid 2.5 MG / pyridoxine 25 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 477459 | cyanocobalamin 2 MG / folic acid 2.5 MG / pyridoxine 25 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 477459 | cyanocobalamin 2 MG / folic acid 2.5 MG / pyridoxine 25 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 477459 | cyanocobalamin 2 MG / folic acid 2.5 MG / pyridoxine 25 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| Concept ID (RxCUI): 477468 | Morphine liposome | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| Concept ID (RxCUI): 477468 | Morphine liposome | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 477468 | Morphine liposome | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 477479 | guaiFENesin 780 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 477479 | guaiFENesin 780 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 477484 | natalizumab 300 MG in 15 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 477484 | natalizumab 300 MG in 15 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 477484 | natalizumab 300 MG in 15 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 477485 | natalizumab 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 477531 | Echinacea purpurea aerial parts extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 477560 | fenofibrate 145 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 477560 | fenofibrate 145 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 477560 | fenofibrate 145 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 477560 | fenofibrate 145 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 477561 | fenofibrate 145 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 477562 | fenofibrate 48 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 477562 | fenofibrate 48 MG Oral Tablet | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 477562 | fenofibrate 48 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 477562 | fenofibrate 48 MG Oral Tablet | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 477563 | fenofibrate 48 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 477582 | allantoin 0.015 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| Concept ID (RxCUI): 477583 | allantoin / pramoxine Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 477585 | guaiFENesin 780 MG / pseudoephedrine HCl 80 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 477585 | guaiFENesin 780 MG / pseudoephedrine HCl 80 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 477585 | guaiFENesin 780 MG / pseudoephedrine HCl 80 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 477585 | guaiFENesin 780 MG / pseudoephedrine HCl 80 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| Concept ID (RxCUI): 477585 | guaiFENesin 780 MG / pseudoephedrine HCl 80 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 477587 | 24 HR brompheniramine maleate 12 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| Concept ID (RxCUI): 477589 | polyethylene glycol 400, 0.4 % / propylene glycol 0.3 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 477589 | polyethylene glycol 400, 0.4 % / propylene glycol 0.3 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| Concept ID (RxCUI): 477589 | polyethylene glycol 400, 0.4 % / propylene glycol 0.3 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| Concept ID (RxCUI): 477590 | propylene glycol 3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 477591 | polyethylene glycol 400 4 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 477592 | polyethylene glycol 400 / propylene glycol Ophthalmic Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| Concept ID (RxCUI): 477598 | pentetate calcium trisodium 200 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| Concept ID (RxCUI): 477604 | zinc-DTPA Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| Concept ID (RxCUI): 477619 | Bacitracin- and neomycin- and polymyxin B-containing product | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| Concept ID (RxCUI): 477619 | Bacitracin- and neomycin- and polymyxin B-containing product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 477619 | Bacitracin- and neomycin- and polymyxin B-containing product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 477622 | CD48 - Cluster of differentiation antigen 48 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 477622 | CD48 - Cluster of differentiation antigen 48 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 477622 | CD48 - Cluster of differentiation antigen 48 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 477622 | CD48 - Cluster of differentiation antigen 48 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 477631 | Secbutabarbital | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 477631 | Secbutabarbital | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 477631 | Secbutabarbital | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 477631 | Secbutabarbital | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 477631 | Secbutabarbital | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 477631 | Secbutabarbital | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 477631 | Secbutabarbital | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 477639 | Caverject | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 477646 | Dolorex brand of acetaminophen-phenyltoloxamine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 4778 | Methylrosanilinium chloride-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 4778 | Methylrosanilinium chloride-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 4778 | Methylrosanilinium chloride-containing product | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 4778 | Methylrosanilinium chloride-containing product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 4778 | Methylrosanilinium chloride-containing product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 4778 | Methylrosanilinium chloride-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 4778 | Methylrosanilinium chloride-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 4778 | Methylrosanilinium chloride-containing product | British preferred term (PTGB) | YES | |
| Concept ID (RxCUI): 4778 | Methylrosanilinium chloride-containing product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 4778 | Methylrosanilinium chloride-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 4778 | Methylrosanilinium chloride-containing product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 477853 | Seedling (substance) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 477853 | Seedling (substance) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 47795 | Leukocyte 11 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 47795 | Leukocyte 11 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 47795 | Leukocyte 11 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 47795 | Leukocyte 11 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 47795 | Leukocyte 11 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 47795 | Leukocyte 11 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 47795 | Leukocyte 11 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 47795 | Leukocyte 11 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 47795 | Leukocyte 11 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 47796 | B-lymphocyte surface antigen B4 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 47796 | B-lymphocyte surface antigen B4 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 47796 | B-lymphocyte surface antigen B4 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 47796 | B-lymphocyte surface antigen B4 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 47796 | B-lymphocyte surface antigen B4 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 47796 | B-lymphocyte surface antigen B4 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 47796 | B-lymphocyte surface antigen B4 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 47796 | B-lymphocyte surface antigen B4 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 47797 | Leukocyte 18 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 47797 | Leukocyte 18 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 47797 | Leukocyte 18 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 47797 | Leukocyte 18 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 47797 | Leukocyte 18 | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 47797 | Leukocyte 18 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 47799 | CD56 - cluster of differentiation 56 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 47799 | CD56 - cluster of differentiation 56 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 47799 | CD56 - cluster of differentiation 56 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 47799 | CD56 - cluster of differentiation 56 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 47799 | CD56 - cluster of differentiation 56 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 47799 | CD56 - cluster of differentiation 56 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 47799 | CD56 - cluster of differentiation 56 | Full form of descriptor (FN) | NO |